With a market cap of $18.8 billion, International Flavors & Fragrances Inc. (IFF) is a global leader in high-value ingredients and solutions serving the food and beverage, health and wellness, home and personal care, and pharmaceutical markets. Operating through four main business units: Nourish; Scent; Health & Biosciences;, and Pharma Solutions, IFF delivers innovative, biotechnology-driven products across a broad range of applications worldwide.
The New York-based company is slated to announce its fiscal Q2 2025 earnings results after the market closes on Tuesday, Aug. 5. Ahead of this event, analysts expect IFF to report an adjusted EPS of $1.10, a 5.2% decline from $1.16 in the year-ago quarter. It has exceeded Wall Street's earnings expectations in three of the past four quarters while missing on another occasion.
